Carl Zeiss Meditec AG announced President Dr. Ludwin Monz will be stepping down from the Executive Board of the company at his own request and by amicable agreement on 31 December 2021. He will be succeeded by Dr. Markus Weber effective 1 January 2022. Dr. Weber is currently a member of the Executive Board of company and is responsible for the ZEISS Semiconductor Manufacturing Technology segment. Jena, 30 September 2021. President and of company, Dr. Ludwin Monz, has announced to the Supervisory Board that he will not be accepting another term in office. The Supervisory Board notes his decision with regret. Dr. Monz and the Supervisory Board agreed to end his term on 31 December 2021. The Supervisory Board has appointed Dr. Markus Weber the new President of Carl Zeiss Meditec AG effective 1 January 2022. As a member of the Executive Board of Carl Zeiss AG, he is currently responsible for the Semiconductor Manufacturing Technology segment and will relinquish his current duties on 31 December 2021. Effective 1 January 2022, alongside Dr. Weber as President three-member Executive Board of Carl Zeiss Meditec AG will continue to comprise Mr. Justus Wehmer as Chief Financial Officer and Mr. Jan Willem de Cler, who is responsible forHuman Resources, Global Service & Customer Care, and Operations. Dr. Ludwin Monz has been at the helm of Carl Zeiss Meditec AG since March 2010, and has been a member of the Executive Board of Carl Zeiss Meditec AG since 2007. Moreover, on 1 January 2014 he was appointed a member of the Executive Board of Carl Zeiss AG. In this role, Dr. Monz is responsible for Corporate Quality Management. Dr. Markus Weber earned his undergraduate degrees and his doctorate at the universities of Karlsruhe and Ulm. He joined ZEISS Semiconductor Manufacturing Technology in 2002 as a research associate.